OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mast cell activation may explain many cases of chemical intolerance
Claudia S. Miller, Raymond F. Palmer, Tania T. Dempsey, et al.
Environmental Sciences Europe (2021) Vol. 33, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Chronically Under-Addressed: Considerations for HCI Accessibility Practice with Chronically Ill People
Kelly Mack, Emma McDonnell, Leah Findlater, et al.
(2022), pp. 1-15
Open Access | Times Cited: 25

Multiple chemical sensitivity: It's time to catch up to the science
John Molot, Margaret Sears, Hymie Anisman
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105227-105227
Open Access | Times Cited: 14

What initiates chemical intolerance? Findings from a large population-based survey of U.S. adults
Claudia S. Miller, Raymond F. Palmer, David Kattari, et al.
Environmental Sciences Europe (2023) Vol. 35, Iss. 1
Open Access | Times Cited: 5

Do no harm: Multiple chemical sensitivity is not psychological
Adrianna Tetley
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 1, pp. 266-267
Open Access | Times Cited: 1

Breast Implant Illness May Be Rooted in Mast Cell Activation: A Case-Controlled Retrospective Analysis
Éva Nagy, Mark Westaway, Suzanne Danieletto, et al.
Annals of Surgery Open (2024) Vol. 5, Iss. 1, pp. e398-e398
Open Access | Times Cited: 1

An introduction to environmental neurotoxicology: Lessons from a clinical perspective
J. Reis, Peter S. Spencer
Journal of the Neurological Sciences (2024) Vol. 463, pp. 123108-123108
Closed Access | Times Cited: 1

Chemical Intolerance and Mast Cell Activation: A Suspicious Synchronicity
Raymond F. Palmer, Tania T. Dempsey, Lawrence B. Afrin
Journal of Xenobiotics (2023) Vol. 13, Iss. 4, pp. 704-718
Open Access | Times Cited: 4

Exploring the mechanism of sweetener neohesperidin dihydrochalcone on oral tolerance via a network pharmacology approach combined with vivo and vitro methods
Xiaolei Shi, JihaoWei, Zhang Yupu, et al.
Journal of Functional Foods (2022) Vol. 95, pp. 105184-105184
Open Access | Times Cited: 5

Disease comorbidities associated with chemical intolerance
R. E. Palmer, Tatjana Walker, RogerB Perales, et al.
Environmental Disease (2021) Vol. 6, Iss. 4, pp. 134-134
Open Access | Times Cited: 6

Assessing Chemical Intolerance in Parents Predicts the Risk of Autism and ADHD in Their Children
Raymond F. Palmer, David Kattari, Rodolfo Rincón, et al.
Journal of Xenobiotics (2024) Vol. 14, Iss. 1, pp. 350-367
Open Access

Inconsistent excipient listings in DailyMed: implications for drug safety
Laurence J. Kinsella, J. Brook, Michelle Briest, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access

Activity-dependent FosB gene expression negatively regulates mast cell functions
Natalia Duque‐Wilckens, Nidia Maradiaga, Szu-Ying Yeh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Effects of the COVID-19 pandemic on individuals with Chemical Intolerance
Raymond F. Palmer, David Kattari, Monica Verduzco‐Gutierrez
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Imatinib and Trigger Avoidance for Mast Cell Activation Syndrome Presenting With Attacks of Abdominal Pain, Nausea, Vomiting, and Diarrhea
Leonard B. Weinstock, Megan Tenkhoff, Jordan Gutovich, et al.
ACG Case Reports Journal (2024) Vol. 11, Iss. 6, pp. e01383-e01383
Open Access

Environmental house calls can reduce symptoms of chemical intolerance: a demonstration of personalized exposure medicine
Rodolfo Rincón, Roger B. Perales, Raymond F. Palmer, et al.
Primary Health Care Research & Development (2024) Vol. 25
Open Access

A genome-wide SNP investigation of chemical intolerance
Raymond F. Palmer, Marcio Almeida, Roger B. Perales, et al.
Environmental Advances (2023) Vol. 12, pp. 100380-100380
Open Access | Times Cited: 1

Environmental House Calls Can Reduce Symptoms of Chemical Intolerance: A Demonstration of Personalized Exposure Medicine
Roger Perales, Rudy Rincon, Jackie V. Forster, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1

What Initiates Chemical Intolerance? Findings from a Large Population-Based Survey of U.S. Adults
Claudia S. Miller, Raymond F. Palmer, David Kattari, et al.
Research Square (Research Square) (2023)
Open Access

Challenging Case in Clinical Practice: Identification and Treatment of Mycotoxin Illness Using an Environmental Medicine Perspective
Alexandra M Quinn, Steven Sandberg-Lewis
Integrative and Complementary Therapies (2023) Vol. 29, Iss. 5, pp. 232-238
Closed Access

Hope for Hypermobility: Part 2—An Integrative Approach to Treating Symptomatic Joint Hypermobility
Victoria Daylor, Cortney Gensemer, Russell A. Norris, et al.
Topics in Pain Management (2023) Vol. 38, Iss. 9, pp. 1-10
Closed Access

An Untargeted Genome-Wide SNP Investigation of Chemical Intolerance
Raymond F. Palmer, Marcio Almeida, Roger B. Perales, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top